EWPI (Emerging World Pharma) EPS (Basic): $ (TTM As of . 20)


What is Emerging World Pharma EPS (Basic)?

Emerging World Pharma EWPI -98.00% EPS (Basic) is $ as of . 20.

Emerging World Pharma's basic earnings per share (Basic EPS) for the three months ended in . 20 was $0.00. Emerging World Pharma does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Emerging World Pharma's EPS (Diluted) for the three months ended in . 20 was $0.00. Emerging World Pharma does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Emerging World Pharma's EPS without NRI for the three months ended in . 20 was $0.00. Emerging World Pharma does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Emerging World Pharma  (OTCPK:EWPI) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Emerging World Pharma EPS (Basic) Related Terms

Emerging World Pharma EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Emerging World Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emerging World Pharma EPS (Basic) Chart

Emerging World Pharma Annual Data
Trend
EPS (Basic)

Emerging World Pharma Quarterly Data
EPS (Basic)

Emerging World Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Emerging World Pharma's Basic EPS for the fiscal year that ended in . 20 is calculated as

Basic EPS (A: . 20 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-)/0
=

Emerging World Pharma's Basic EPS for the quarter that ended in . 20 is calculated as

Basic EPS (Q: . 20 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-)/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $ mean?
Emerging World Pharma (EWPI) has a EPS (Basic) of $ as of . 20. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Emerging World Pharma and its competitors.
Is Emerging World Pharma's EPS (Basic) too high?
Emerging World Pharma's current EPS (Basic) is $.
How does Emerging World Pharma's EPS (Basic) compare to ENZB and AOXG?
Emerging World Pharma's EPS (Basic) of $ can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Emerging World Pharma and its competitors. Emerging World Pharma's current EPS (Basic) is $. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emerging World Pharma stock overvalued right now?
Emerging World Pharma (EWPI) has a current EPS (Basic) of $. The current EPS (Basic) is $. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Emerging World Pharma (EWPI), the current EPS (Basic) is $ as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emerging World Pharma Business Description

Address Block 11A, Pastoral Road, Sunyani, GHA, 20109
Emerging World Pharma Inc is an investor in generic based pharmaceutical companies manufacturing within developing nations.